NZ573614A - Processes for making caralluma extracts and uses - Google Patents
Processes for making caralluma extracts and usesInfo
- Publication number
- NZ573614A NZ573614A NZ573614A NZ57361404A NZ573614A NZ 573614 A NZ573614 A NZ 573614A NZ 573614 A NZ573614 A NZ 573614A NZ 57361404 A NZ57361404 A NZ 57361404A NZ 573614 A NZ573614 A NZ 573614A
- Authority
- NZ
- New Zealand
- Prior art keywords
- caralluma
- extract
- composition
- composition according
- glycosides
- Prior art date
Links
- 241000517186 Caralluma Species 0.000 title claims abstract description 186
- 239000000284 extract Substances 0.000 title claims abstract description 166
- 238000000034 method Methods 0.000 title description 86
- 230000008569 process Effects 0.000 title description 62
- 229930182470 glycoside Natural products 0.000 claims abstract description 125
- 239000011347 resin Substances 0.000 claims abstract description 68
- 229920005989 resin Polymers 0.000 claims abstract description 68
- 239000000203 mixture Substances 0.000 claims abstract description 60
- -1 pregnane glycosides Chemical class 0.000 claims abstract description 41
- 241000196324 Embryophyta Species 0.000 claims abstract description 36
- 239000002417 nutraceutical Substances 0.000 claims abstract description 13
- 235000021436 nutraceutical agent Nutrition 0.000 claims abstract description 13
- 229930190237 caratuberside Natural products 0.000 claims abstract description 8
- 208000008589 Obesity Diseases 0.000 claims abstract description 5
- 235000020824 obesity Nutrition 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- WXLJRYSLYQBMGF-RUFGMRSTSA-N CO[C@@H]1[C@@H](O)[C@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C(C)=O)C2)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O Chemical compound CO[C@@H]1[C@@H](O)[C@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C(C)=O)C2)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O WXLJRYSLYQBMGF-RUFGMRSTSA-N 0.000 claims abstract description 3
- 230000002195 synergetic effect Effects 0.000 claims abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 17
- 238000000354 decomposition reaction Methods 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 11
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 11
- 229930182490 saponin Natural products 0.000 claims description 11
- 230000009467 reduction Effects 0.000 claims description 10
- 239000011230 binding agent Substances 0.000 claims description 9
- 244000292211 Canna coccinea Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- 244000215068 Acacia senegal Species 0.000 claims description 3
- 235000006491 Acacia senegal Nutrition 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 230000003502 anti-nociceptive effect Effects 0.000 claims description 3
- 230000001754 anti-pyretic effect Effects 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 239000002221 antipyretic Substances 0.000 claims description 3
- 230000002026 carminative effect Effects 0.000 claims description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 3
- 239000001095 magnesium carbonate Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 241000221239 Capparis lasiantha Species 0.000 claims description 2
- 241000284832 Caralluma stalagmifera Species 0.000 claims description 2
- 241001504021 Caralluma tuberculata Species 0.000 claims description 2
- 241000178100 Ceropegia attenuata Species 0.000 claims description 2
- 244000295519 Chimaphila umbellata Species 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 240000003450 Mallotus philippensis Species 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000507 anthelmentic effect Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 239000009355 kamala Substances 0.000 claims description 2
- 230000037323 metabolic rate Effects 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 241000221868 Ceratocystis fimbriata Species 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 239000013585 weight reducing agent Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 description 99
- 238000000605 extraction Methods 0.000 description 86
- 150000002338 glycosides Chemical class 0.000 description 85
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 239000000047 product Substances 0.000 description 59
- 239000000463 material Substances 0.000 description 54
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 49
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- 241000894007 species Species 0.000 description 19
- 238000000227 grinding Methods 0.000 description 17
- 238000001035 drying Methods 0.000 description 15
- 239000001814 pectin Substances 0.000 description 14
- 229920001277 pectin Polymers 0.000 description 14
- 235000010987 pectin Nutrition 0.000 description 14
- 239000011877 solvent mixture Substances 0.000 description 14
- 239000001648 tannin Substances 0.000 description 14
- 229920001864 tannin Polymers 0.000 description 14
- 235000018553 tannin Nutrition 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 12
- 230000008020 evaporation Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000002156 mixing Methods 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- 238000011084 recovery Methods 0.000 description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000607142 Salmonella Species 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000011143 downstream manufacturing Methods 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 238000003801 milling Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960004592 isopropanol Drugs 0.000 description 4
- 238000013021 overheating Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010033546 Pallor Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- AMDCWRHQFJRCAD-UHFFFAOYSA-N 2-[5-hydroxy-6-[[14-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound COC1C(O)C(OC2CC3C(C4C(C5(CCC(C5(C)CC4)C(C)O)O)CC3)(C)CC2)OC(C)C1OC1OC(CO)C(O)C(O)C1O AMDCWRHQFJRCAD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 241001504107 Desmidorchis retrospiciens Species 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 2
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 238000000622 liquid--liquid extraction Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- JWMFYGXQPXQEEM-WZBAXQLOSA-N pregnane group Chemical group [C@@H]12CC[C@H](CC)[C@@]1(C)CC[C@H]1[C@H]2CCC2CCCC[C@]12C JWMFYGXQPXQEEM-WZBAXQLOSA-N 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005979 thermal decomposition reaction Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- JWMFYGXQPXQEEM-NUNROCCHSA-N 5β-pregnane Chemical compound C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](CC)[C@@]2(C)CC1 JWMFYGXQPXQEEM-NUNROCCHSA-N 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001504156 Caralluma adscendens Species 0.000 description 1
- 241001504101 Caralluma penicillata Species 0.000 description 1
- 241001605900 Ceropegia fimbriata Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020071 rectified spirit Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN451CH2003 | 2003-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ573614A true NZ573614A (en) | 2011-02-25 |
Family
ID=36011983
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ573614A NZ573614A (en) | 2003-06-04 | 2004-05-31 | Processes for making caralluma extracts and uses |
| NZ543995A NZ543995A (en) | 2003-06-04 | 2004-05-31 | Processes for making caralluma extracts and uses |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ543995A NZ543995A (en) | 2003-06-04 | 2004-05-31 | Processes for making caralluma extracts and uses |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7060308B2 (https=) |
| EP (1) | EP1644013A1 (https=) |
| JP (2) | JP5260873B2 (https=) |
| KR (2) | KR20060034229A (https=) |
| CN (1) | CN1798566B (https=) |
| AU (2) | AU2004244850B2 (https=) |
| BR (1) | BRPI0411400A (https=) |
| CA (1) | CA2527702C (https=) |
| CO (1) | CO5660269A2 (https=) |
| NZ (2) | NZ573614A (https=) |
| WO (1) | WO2004108148A1 (https=) |
| ZA (1) | ZA200509780B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060083795A1 (en) * | 2004-10-19 | 2006-04-20 | Lima Shatkina | Meal replacement products having appetite suppressing qualities |
| KR101307999B1 (ko) * | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
| CA2596311A1 (en) * | 2005-01-20 | 2006-07-27 | Stephen Holt | Herbal compositions containing hoodia |
| WO2007022141A1 (en) * | 2005-08-17 | 2007-02-22 | Charles Tadlock | Delivery system for appetite suppressant |
| CA2660464A1 (en) * | 2006-08-17 | 2008-02-21 | Unilever Plc | Processes for production of hoodia plant extracts containing steroidal glycosides |
| WO2008107910A2 (en) * | 2007-03-05 | 2008-09-12 | Ramaswamy Rajendran | Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same |
| US8247547B2 (en) * | 2009-01-30 | 2012-08-21 | Ghare Vishwas Sadhu | Process for the preparation of Caralluma extract and a formulation prepared thereof |
| US20130122146A1 (en) * | 2011-11-16 | 2013-05-16 | Decas Botanical Synergies, Llc | Process for Spray Drying Botanical Food |
| US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
| US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
| US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
| WO2014178394A1 (ja) | 2013-04-30 | 2014-11-06 | 日本臓器製薬株式会社 | 抽出物及び該抽出物を含有する製剤 |
| EP2810565A1 (en) * | 2013-06-03 | 2014-12-10 | Dupont Nutrition Biosciences ApS | Antioxidant composition |
| CN103969393A (zh) * | 2014-04-25 | 2014-08-06 | 上海相宜本草化妆品股份有限公司 | 用于化妆品中糖苷类中草药化合物含量测试的前处理方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3960839A (en) * | 1973-02-09 | 1976-06-01 | Escuela Politecnica Nacional | Process for recovering and isolating solasodine and glycosides thereof |
| US5270457A (en) * | 1992-06-12 | 1993-12-14 | University Of Manitoba | Cardiac steriod glycosides |
| GB2338235B (en) | 1997-04-15 | 2001-11-14 | Csir | Appetite suppressing plant extracts |
| EP0931550B1 (en) * | 1998-01-26 | 2004-09-22 | National Research Development Corporation, a Government of India Undertaking | A process for the preparation of a spermicidal agent |
| US6703051B1 (en) | 1998-10-13 | 2004-03-09 | Solae, Llc | Process for separating and recovering protein and isoflavones from a plant material |
| US6124442A (en) * | 1999-03-24 | 2000-09-26 | Zhou; James H. | Process for extracting triterpene glycosides from botanical sources |
| US6224906B1 (en) * | 1999-08-31 | 2001-05-01 | Natreon Inc. | St. John's wort composition |
| US6635758B2 (en) * | 2000-09-25 | 2003-10-21 | Industrial Technology Research Institute | Process for extracting glycoside using an aqueous two-phase system |
| EP1448213A2 (en) * | 2001-11-16 | 2004-08-25 | Novartis Nutrition AG | Plant derived or derivable material with appetite suppressant activity |
-
2004
- 2004-05-04 US US10/837,613 patent/US7060308B2/en not_active Expired - Lifetime
- 2004-05-31 BR BRPI0411400-0A patent/BRPI0411400A/pt not_active Application Discontinuation
- 2004-05-31 NZ NZ573614A patent/NZ573614A/en not_active IP Right Cessation
- 2004-05-31 CA CA2527702A patent/CA2527702C/en not_active Expired - Lifetime
- 2004-05-31 EP EP04735495A patent/EP1644013A1/en not_active Ceased
- 2004-05-31 CN CN200480015265.3A patent/CN1798566B/zh not_active Expired - Lifetime
- 2004-05-31 AU AU2004244850A patent/AU2004244850B2/en not_active Expired
- 2004-05-31 NZ NZ543995A patent/NZ543995A/en not_active IP Right Cessation
- 2004-05-31 WO PCT/IN2004/000150 patent/WO2004108148A1/en not_active Ceased
- 2004-05-31 KR KR1020057023343A patent/KR20060034229A/ko not_active Ceased
- 2004-05-31 KR KR1020077024499A patent/KR100993487B1/ko not_active Expired - Lifetime
- 2004-05-31 JP JP2006508488A patent/JP5260873B2/ja not_active Expired - Lifetime
-
2005
- 2005-03-18 US US11/083,226 patent/US7390516B2/en not_active Expired - Lifetime
- 2005-12-01 ZA ZA200509780A patent/ZA200509780B/en unknown
- 2005-12-02 CO CO05122635A patent/CO5660269A2/es not_active Application Discontinuation
-
2008
- 2008-12-12 AU AU2008255233A patent/AU2008255233B2/en not_active Expired
-
2012
- 2012-11-22 JP JP2012256942A patent/JP2013067638A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0411400A (pt) | 2006-07-25 |
| JP2006526615A (ja) | 2006-11-24 |
| US20040247702A1 (en) | 2004-12-09 |
| JP2013067638A (ja) | 2013-04-18 |
| CN1798566B (zh) | 2014-03-12 |
| US7390516B2 (en) | 2008-06-24 |
| KR100993487B1 (ko) | 2010-11-10 |
| EP1644013A1 (en) | 2006-04-12 |
| CO5660269A2 (es) | 2006-07-31 |
| JP5260873B2 (ja) | 2013-08-14 |
| AU2004244850A2 (en) | 2004-12-16 |
| CA2527702A1 (en) | 2004-12-16 |
| US7060308B2 (en) | 2006-06-13 |
| KR20060034229A (ko) | 2006-04-21 |
| AU2004244850A1 (en) | 2004-12-16 |
| ZA200509780B (en) | 2006-09-27 |
| KR20070114833A (ko) | 2007-12-04 |
| AU2004244850B2 (en) | 2009-01-08 |
| AU2008255233B2 (en) | 2012-01-12 |
| US20050163871A1 (en) | 2005-07-28 |
| NZ543995A (en) | 2009-02-28 |
| CN1798566A (zh) | 2006-07-05 |
| WO2004108148A1 (en) | 2004-12-16 |
| CA2527702C (en) | 2016-03-08 |
| AU2008255233A1 (en) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008255233B2 (en) | Processes for making caralluma extracts and uses | |
| KR102171001B1 (ko) | 안토시아닌 함량 및 비만억제 효능이 증진된 아로니아 추출물의 제조방법 및 그의 조성물 | |
| CN1506373A (zh) | 从竹子中提取的三萜总皂甙元的组成、方法及其用途 | |
| CN108743696B (zh) | 具有促进伤口愈合的胆木提取物及其应用 | |
| JP2006526615A5 (https=) | ||
| KR101625474B1 (ko) | 진세노사이드 알에이치4의 대량 제조방법 | |
| CN103040882A (zh) | 紫果西番莲茎及叶提取物及其药物组合物与抗抑郁作用 | |
| CA2980231A1 (en) | Pharmaceutical composition containing silybin | |
| KR20130083427A (ko) | Ｐｐａｒ 작용 조절 질환의 예방, 개선 또는 치료용 조성물 | |
| CN111920799B (zh) | 一种苦乐果有效成分组合物及其制备方法和应用 | |
| CN101732377A (zh) | 具有抗癌作用的刺人参叶总皂苷提取物的制备方法 | |
| KR102698224B1 (ko) | 생잎을 이용한 돌외잎차의 제조방법 및 이에 따라 제조된 돌외잎차를 이용한 돌외잎차 추출물의 제조방법 | |
| MXPA05013031A (en) | Processes for making caralluma extracts and uses | |
| US8247547B2 (en) | Process for the preparation of Caralluma extract and a formulation prepared thereof | |
| CN103751242A (zh) | 生产水牛掌属植物萃取物 | |
| JP5441433B2 (ja) | カムカムフルーツ果汁含有肝機能改善剤 | |
| CN103845343B (zh) | 山核桃甾醇提取物在制备消炎物品中的应用 | |
| CN1709225A (zh) | 利用虎杖提取物制备辅助抑制肿瘤保健食品的方法 | |
| Singh et al. | EFFECT OF ETHANOLIC EXTRACT OF CESTRUM NOCTURNUM LEAVES ON BLOOD GLUCOSE LEVEL OF STREPTOZOTOCIN-INDUCED DIABETIC ALBINO WISTAR RATS | |
| WO2013183064A2 (en) | Extraction of phytochemicals from trichilia connaroides | |
| CN107050372A (zh) | 一种防治虹鳟肝胆综合症的中药组合物及其制备方法 | |
| JP2006306801A (ja) | アカシア属樹皮由来物を含有する腫瘍の予防及び／又は治療用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 31 MAY 2017 BY PIPERS Effective date: 20140203 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 MAY 2018 BY PIPERS Effective date: 20170301 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 MAY 2019 BY PIPERS Effective date: 20180301 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 MAY 2020 BY PIPERS Effective date: 20190304 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 MAY 2021 BY PIPERS Effective date: 20200304 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 MAY 2022 BY PIPERS Effective date: 20210422 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 MAY 2023 BY PIPERS Effective date: 20220228 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 MAY 2024 BY PIPERS Effective date: 20230228 |
|
| EXPY | Patent expired |